TEVA
Teva Pharma Industries Ltd
38.90$
-0.8%
vs. previous close
Closing price · As of: Sep 28, 2026
Filings
Filings
Listed US companies must report material events to the Securities and Exchange Commission. This page lists the filings of Teva Pharma Industries Ltd (TEVA) with date, type and a link to the original document.
| Date | Type | Filing | Original |
|---|---|---|---|
| 09/16/2026 | Current report (8-K) | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA): Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; Financial Statements and Exhibits | View report ↗ |
| 09/14/2026 | Current report (8-K) | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA): Other Events | View report ↗ |
| 09/11/2026 | Current report (8-K) | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA): Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View report ↗ |
| 09/03/2026 | Current report (8-K) | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA): Other Events; Financial Statements and Exhibits | View report ↗ |
| 09/03/2026 | Current report (8-K) | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA): Material Modifications to Rights of Security Holders; Financial Statements and Exhibits | View report ↗ |
Showing the 100 most recent filings of the selected type.
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Filings: SEC EDGAR
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.